JPRN-UMIN000008069已完成未知
Study on reintroduction regimen of antituberculous therapy after developing of drug-induced hepatotoxicity (DIH) - Study on reintroduction regimen of antituberculous therapy after developing of drug-induced hepatotoxicity (DIH)
ational Center for Global Health and Medicine0 个研究点目标入组 50 人开始时间: 2012年5月31日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)HIV infection 2)Pregnancy of breast-feeding 3)Liver cirrhosis 4)Acute or chronic hepatitis infection 5)Known resistance against INH or RFP 6)Persistent liver damage 7)Abnormal laboratory finding; WBC <2,000/mm3, Hgb <7g/dL, Platelet count <50,000/mm3 8)Patients whom the attending physician decided unsuitable for entering the present study
研究者
相似试验
进行中（未招募）
4 期
Anti-TB therapy following drug-induced liver injury (TB-DILI)Drug induced liver injury in patients receiving tuberculosis treatment.RespiratoryISRCTN92067975ottingham Clinical Trials Unit350
招募中
不适用
Investigation of serum level of antituberculous and genetic polymorphism in NAT2 gene in patinet with pulmonary tuberculosispulmonary tuberculosisJPRN-UMIN000006664Fukushima Medeical University20
尚未招募
3 期
Multi-mOnth Refill of Anti-TB Drugs (MORAD) study in rural eastern UgandaTuberculosisPACTR202403586718783niversity of California Berkeley260
Unknown
4 期
Reintroduction Regimens After Hepatitis During Anti-tuberculosis TreatmentTuberculosis, PulmonaryHepatitisNCT01395654National Taiwan University Hospital100
尚未招募
不适用
Comparison of oral medication and surgery to treat tuberculosis of middle ear.CTRI/2020/03/024147Karpaga Vinayaka Institute of Medical sciences